|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Sodium glucose co-transporter 2 inhibition reduces succinate levels in diabetic mice显示文摘BACKGROUND Type 1 diabetes(T1D) is associated with major chronic microvascular complications which contribute significantly to diabetes associated morbidity.The protein primarily responsible for glucose reabsorption in the kidney is sodium glucose co-transporter 2(SGLT2). Presently, SGLT2 inhibitors are widely used in diabetic patients to improve blood glucose levels and prevent cardiovascular and renal complications. Given the broad therapeutic application of SGLT2 inhibitors, we hypothesised that SGLT2 inhibition may exert its protective effects via alterations of the gut microbiome and tested this in a type 1 diabetic mouse model of diabetic retinopathy.AIM To determine whether the treatment with two independent SGLT2 inhibitors affects gut health in a type 1 diabetic mouse model.METHODS The SGLT2 inhibitors empagliflozin or dapagliflozin(25 mg/kg/d) or vehicle dimethylsulfoxide(DMSO) were administered to C57 BL/6 J, Akita, Kimba and Akimba mice at 10 wk of age for 8 wk via their drinking water. Serum samples were collected and the concentration of succinate and the short chain fatty acid(SCFA) butyric acid was measured using gas chromatography-mass spectrometry. Enzyme-linked immunosorbent assay(ELISA) was performed to determine the concentration of insulin and leptin. Furthermore, the norepinephrine content in kidney tissue was determined using ELISA. Pancreatic tissue was collected and stained with haematoxylin and eosin and analysed using brightfield microscopy.RESULTS Due to the presence of the Akita allele, both Akita and Akimba mice showed a reduction in insulin production compared to C57 BL/6 J and Kimba mice.Furthermore, Akita mice also showed the presence of apoptotic bodies within the pancreatic islets. The acinar cells of Akita and Akimba mice showed swelling which is indicative of acute injury or pancreatitis. After 8 wk of SGLT2 inhibition with dapagliflozin, the intermediate metabolite of gut metabolism known as succinate was significantly reduced in Akimba mice when compared to DMSO treated mice. In addition, empagliflozin resulted in suppression of succinate levels in Akimba mice. The beneficial SCFA known as butyric acid was significantly increased in Akita mice after treatment with dapagliflozin when compared to vehicle treated mice. The norepinephrine content in the kidney was significantly reduced with both dapagliflozin and empagliflozin therapy in Akita mice and was significantly reduced in Akimba mice treated with empagliflozin.In non-diabetic C57 BL/6 J and Kimba mice, serum leptin levels were significantly reduced after dapagliflozin therapy.CONCLUSION The inhibition of SGLT2 reduces the intermediate metabolite succinate, increases SCFA butyric acid levels and reduces norepinephrine content in mouse models of T1 D. Collectively, these improvements may represent an important mechanism underlying the potential benefits of SGLT2 inhibition in T1 D and its complications. | Lakshini Y Herat Natalie C Ward Aaron L Magno Elizabeth P Rakoczy Marcio G Kiuchi Markus P Schlaich Vance B Matthews | 2020 | World Journal of Gastroenterology2020，26，23： | 3 |
| 2 | Inhibition of constitutive aryl hydrocarbon receptor ( AhR ) signaling attenuates androgen independent signaling and growth in ( C4-2 ) prostate cancer cells显示文摘 | Tran C Richmond O Aaron L | 2013 | Biochemical Pharmacology2013，85，6： | 1 |
| 3 | Blood pressure, atherosclerosis, and albuminuria in 10 113 participants in the Atherosclerosis Risk In Communities study显示文摘 | Charles C Hsu Frederick L Brancati Brad C Astor Wen Hong Kao Michael W Steffes Aaron R Folsom Josef Coresh | 2009 | Journal of Hypertension2009，，2： | 1 |
| 4 | Ubiquitin-mediated degradation in health and disease 显示文摘 | AARON C SCHWARTZ A L | 2002 | Hepalology2002，35，1： | 1 |
| 5 | Rituximab therapy for HIV-associated Castleman disease 显示文摘 | Marcelin A Aaron L Mateus C | 2003 | Blood2003，102，8： | 1 |
| 6 | The United Kingdom public health re- sponse to an imported laboratory confirmed case of a no- vel coronavirus in September 2012显示文摘 | Pebody R G Chand M A Thomas H L Green H K Boddington N L Carvalho C Brown C S Anderson S R Rooney C Crawley-Boevey E Irwin D J Aarons E Tong C Newsholme W Price N Langrish C Tucker D Zhao H Phin N Crofts J Bermingham A Gil- gunn-Jones E Brown K E Evans B Catchpole M Watson J M | 2012 | Euro Surveill2012，17，20： | 1 |
| 7 | I Rituximab therapy for HIV - associated Castleman disease 显示文摘 | Marcelin AG Aaron L Mateus C | 2003 | Blood2003，102，8： | 1 |
| 8 | Fluorescence resonance energy transfer between Ouantum Dotdonors dyelabeled protein accptors 显示文摘 | Aaron R C Medintz L L Matthew M | 2004 | Journal of Polymer Science Part A: Polymer Chemistry2004，126，： | 1 |
| 9 | Use of biofilters and suspended growth reactors to treat VOCs显示文摘 | Aaron B N Raymond C L | 2000 | Waste Management2000，20，1： | 1 |
| 10 | Enduring effect of chronic corticosterone treatment on spatial learning,synaptic plasticity,and hippocampal neuropathology in young and mid-aged rats显示文摘 | SHARI R B AARON G H JEMMIFER C L | 1995 | J Neurosci1995，15，1： | 1 |
| 11 | Carbun isotope signatures of fatty acids in Geobacter metallireducens and Shewanella algae 显示文摘 | Chuanlun L Zhang Lia Yiliang Qi Ye Jon Fong Aaron D Peacock Elizabeth Blunt Fang Jiasong Derek R Eovley David C White | 2003 | Chemical Geology2003，195，： | 1 |
| 12 | 5 Kathy, Optical and Acoustical Dynamics of Microbubble Contrast Agents inside Neutrophils 显示文摘 | Paul A D James E C Aaron F H L | 2001 | Biophysical Journal2001，80，： | 1 |
| 13 | Human herpesvirus 8-positive Castleman disease in human immunodeficiency virus-infected patients: the impact of highly active antiretroviral therapy 显示文摘 | Aaron L Lidove O Yousry C | 2002 | Clin Infect Dis2002，35，7： | 1 |
| 14 | Predi-ction of isothermal equation of state of an explo- sive nitrate ester by van der waals density func- tional theory显示文摘 | Aaron C L Michael W C Ivan ! O | 2010 | Journal of Physical Chemistry letters2010，1，1： | 1 |
| 15 | Rituximab therapy for HIV-associated Castleman disease显示文摘 | Marcelin A G Aaron L Mateus C | 2003 | Blood2003，102，10： | 1 |
| 16 | Ubiquitous GFP expression in transgenic chickens using a lentiviral vector显示文摘 | Susan C C Aaron L William C | 2005 | Development2005，132，5： | 1 |
| 17 | Production of α-1,3-galactosyltransferase knockout Pigs by nuclear transfer cloning显示文摘 | Donna K S Kwang W P Hee T C Julia L G Gi S I Melissa S Aaron B August R Billy N D Clifton N M David B C Robert J H Randall S P | 2002 | Science2002，295，5557： | 1 |
| 18 | Rituximab therapy for HIV- associated Castleman disease 显示文摘 | Mareelin AG Aaron L Mateus C | 2003 | Blood2003，102，8： | 1 |
| 19 | Suppression subtractive hybridization: A method for generating differentially regulated or tissue-specific cDNA probes and libraries 显示文摘 | Luda D Yun-Fai C L Aaron P C | 1996 | Proc Natl Acad Sci USA1996，93，： | 1 |
| 20 | New and emerging radiosensitizersand radioprotectors显示文摘 | Aaron C S Theodore S L | 2006 | Cancer Invest2006，24，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员